The typical case for the fund is to invest in rounds with 3 participants. Despite the Servier Canada, startups are often financed by Fonds de solidaritu00e9 FTQ, CTI Life Sciences Fund. The meaningful sponsors for the fund in investment in the same round are Fonds de solidaritu00e9 FTQ, CTI Life Sciences Fund. In the next rounds fund is usually obtained by Fonds de solidaritu00e9 FTQ, CTI Life Sciences Fund.
The top activity for fund was in 2016. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
Among the most popular portfolio startups of the fund, we may highlight ILKOS Therapeutic, ILKOS Therapeutic. Among the most successful fund investment fields, there are Medical, Health Care.
| Fund Name | Location |
| 8i Ventures | India, Maharashtra, Mumbai |
| Automation Alley | Michigan, Troy, United States |
| BENCHACHINDA HOLDING COMPANY LIMITED | - |
| Colman Partners | California, Corte Madera, United States |
| EV | - |
| Excell Technology Ventures | - |
| Formative Ventures | California, Santa Clara, United States |
| Good News Ventures | Canada, Ontario, Toronto |
| Ingram Micro | California, Irvine, United States |
| Newfort Capital | - |
| Nokia Venture Partners | California, Kentucky, United States |
| Old Lane LP | New York, New York, United States |
| Permal Asset Management | New York, New York, United States |
| Solar Group | India, Maharashtra, Nagpur |
| Stratim Capital | California, San Francisco, United States |
| Sud Angels | France, Languedoc-Roussillon, Montpellier |
| Suzhou Haihui Jijin | China, Jiangsu, Suzhou |
| Vertical Venture Partners | California, Menlo Park, United States |
| Vidal Healthcare | Bangalore, India, Karnataka |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ILKOS Therapeutic | $21M | 01 Aug 2016 | Quebec |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ILKOS Therapeutic | $21M | 01 Aug 2016 | Quebec |
